OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
22 avr. 2024 08h00 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and...
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
27 févr. 2024 16h05 HE
|
OraSure Technologies, Inc.
Q4 GAAP EPS of $0.27; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 Enters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics...
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
13 févr. 2024 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and...
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
04 janv. 2024 07h05 HE
|
OraSure Technologies, Inc.
The relationship expands OraSure’s innovation pipeline with access to a broad portfolio of key Sapphiros products in development. Distribution of Sapphiros’ products is expected to accelerate...
OraSure to Participate in Upcoming Investor Conferences
13 nov. 2023 16h15 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome...
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
07 nov. 2023 16h05 HE
|
OraSure Technologies, Inc.
Q3 GAAP EPS of $0.15; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:...
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
23 oct. 2023 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and...
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
03 août 2023 16h05 HE
|
OraSure Technologies, Inc.
InteliSwab® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of $(0.07); Q2 Non-GAAP EPS of $0.09 Grew cash...
OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd
20 juil. 2023 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and...
OraSure Technologies Elects Robert McMahon to the Board of Directors
20 juil. 2023 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome...